Delivery Order SPE2DB22D3019-SPE2DB25FK3NY
- Not listed
- The Defense Logistics Agency (DLA) awarded a $10,274.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Dupixent 300 mg/2 ml syringes. The contract, with an ultimate completion date of November 5, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $24,783.94 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes on November 18, 2025, with completion expected by November 19, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor at its corporate office location in Conshohocken, Pennsylvania. The order represents a single transaction under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,840.94 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes. This firm fixed price, competitively awarded delivery order was issued on October 20, 2025, with an ultimate completion date of October 21, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for Dupixent 300mg/2ml syringes valued at $44,390.30. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 20, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The award does not utilize a set-aside designation and represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a $11,458.33 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen injectors on June 13, 2025, with an ultimate completion date of June 16, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,548.41 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on October 21, 2025, with an ultimate completion date of October 22, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Dupixent 300 mg/2 ml syringes with a ceiling value of $2,451.15. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of October 21, 2025. This delivery order represents a single transaction under...
- The Defense Logistics Agency has awarded a delivery order valued at $9,986.44 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes. This competitively awarded, firm fixed-price contract was issued on August 28, 2025, with an ultimate completion date of August 29, 2025. The product will be supplied from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $60,479.19 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes on a firm fixed price basis. The award, issued on November 5, 2025, with an ultimate completion date of November 6, 2025, represents a non-competitive set-aside delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,749.55 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes on August 26, 2025, with an ultimate completion date of August 27, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The award specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- SPE2DB22D3019Indefinite Delivery Contract
- SPE2DB22D3019-SPE2DB25FK3NYDelivery Order
The Defense Logistics Agency (DLA) awarded a $48,029.65 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml syringes on April 30, 2025, with completion scheduled for May 1, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. No set-aside designation was applied to this award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. The SPE2DX indefinite delivery vehicle functions as a comprehensive global pharmaceutical support contract enabling AmerisourceBergen to supply medications, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. This delivery order for Dupixent, a specialty pharmaceutical used for immunological conditions, exemplifies the company's ongoing role in fulfilling federal medical supply requirements through competitive contracting mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $48.0k | 4/30/25 |